The award will support the development of diagnostics and analytical tools for childhood disease detection using tissue-based fluorescent in situ sequencing.
Organizations are pursuing various approaches to control mosquitos harboring dengue and Zika viruses, Technology Review reports.
Researchers at Smith College used NGS and a Galaxy-based software called RepeatExplorer to design improved assays for soil-transmitted helminths.
Affymetrix has created a new custom genotyping array for the project, which aims to increase rice production for small farms in Africa and Asia.
The company is currently in discussions with several investor groups and plans to use the funds to expand the reach of the test and prepare for FDA submission.
Intended for diagnosing active pulmonary tuberculosis, the test will use Cere's Nanotrap reagents for enriching target analytes for downstream analysis.
Three philanthropies have teamed up on a new program to support early career researchers in the biomedical sciences.
Cepheid is now considering adapting TB tests in development to cover the mutations, an executive told GenomeWeb.
With the additional funding, Sera aims to develop new tests for predicting the risk of preterm birth in women in developing countries, the company said.
The data repository of tuberculosis drug susceptibility will spur diagnostic assay development; access will be open to partner firms in one year.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.